To see the efficacy of oral minoxidil versus topical minoxidil in male pattern hair loss.

Comparison Of efficacy Of oral minoxidil 1.25mg vs topical minoxidil 5% in male androgenetic alopecia -a randomised open label pilot study. - nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063576

Enrollment

Registered

2024-03-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: oral minoxidil 1.25mg : tablet minoxidil 1.25mg once daily for 24 weeks follow up every 4-weekly for 24weeks Control Intervention1: 5 % minoxidil solution: 4-weekly for 24 weeks. Contro

Eligibility

Inclusion criteria

Inclusion criteria: 1.All males aged 18-45 yrs of age 2. Males with ( Hamilton Norwood Scale II-IV)

Exclusion criteria

Exclusion criteria: 1.Severe hypertension, moderate hypertension on antihypertensive therapy 2.Cardiovascular dysfunction 3.History of minoxidil hypersensitivity 4.On treatment with formulation of minoxidil, DHT- blockers or other treatments for AGA in the past 3 months. 5.Psychiatric or scalp disease

Design outcomes

Primary

Measure	Time frame
1.Clinical photographic assessment and quantitative assessment using densitometer will be done. 2.Hair density calculation will be done in a square inch areaTimepoint: every monthly for 6 months	—

Secondary

Measure	Time frame
The number of vellus hairs, terminal hairs determined by their thickness in the specific square inch areaTimepoint: every monthly for 6 months	—

Countries

India

Contacts

Public ContactBikash Ranjan Kar

IMS and Sum hospital

karbikash@gmail.com9937428181

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026